Search

    Edition and Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    usreport
    usreport

    Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

    1 hour ago

    Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

    Click here to Read More
    Previous Article
    A New World Order Is Coming. We Aren’t Ready.
    Next Article
    U.S. Launches Airstrikes on Iran for 2nd Time in Three Days

    Related Breaking News Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment